Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemorrhagic Fever, Ebola | 17 | 2026 | 33 | 2.570 |
Why?
|
| Genome, Viral | 19 | 2021 | 119 | 2.540 |
Why?
|
| Viruses | 7 | 2024 | 39 | 2.460 |
Why?
|
| Ebolavirus | 16 | 2026 | 49 | 2.390 |
Why?
|
| Phylogeny | 19 | 2025 | 769 | 1.660 |
Why?
|
| Rickettsia | 2 | 2025 | 3 | 1.150 |
Why?
|
| Burkholderia pseudomallei | 3 | 2025 | 40 | 1.120 |
Why?
|
| Antibodies, Viral | 7 | 2026 | 306 | 1.090 |
Why?
|
| Disease Outbreaks | 13 | 2023 | 175 | 1.030 |
Why?
|
| Peptide Library | 2 | 2025 | 28 | 0.990 |
Why?
|
| Melioidosis | 2 | 2025 | 27 | 0.940 |
Why?
|
| Dermacentor | 1 | 2025 | 3 | 0.920 |
Why?
|
| Rickettsia rickettsii | 1 | 2025 | 3 | 0.910 |
Why?
|
| Virus Diseases | 1 | 2024 | 27 | 0.860 |
Why?
|
| Antigens, Bacterial | 1 | 2025 | 144 | 0.850 |
Why?
|
| Sequence Analysis, DNA | 10 | 2017 | 515 | 0.850 |
Why?
|
| Bacterial Vaccines | 1 | 2025 | 129 | 0.840 |
Why?
|
| Anthozoa | 3 | 2013 | 23 | 0.840 |
Why?
|
| Immunosorbents | 1 | 2022 | 1 | 0.770 |
Why?
|
| Onygenales | 1 | 2022 | 2 | 0.760 |
Why?
|
| Dermatomycoses | 1 | 2022 | 7 | 0.750 |
Why?
|
| Proteomics | 1 | 2022 | 378 | 0.640 |
Why?
|
| RNA, Viral | 8 | 2019 | 321 | 0.630 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.580 |
Why?
|
| Genetic Variation | 4 | 2016 | 430 | 0.580 |
Why?
|
| Communicable Disease Control | 1 | 2019 | 38 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.580 |
Why?
|
| Communicable Diseases | 1 | 2019 | 47 | 0.570 |
Why?
|
| Evolution, Molecular | 4 | 2020 | 307 | 0.560 |
Why?
|
| Animals | 32 | 2026 | 16992 | 0.550 |
Why?
|
| Dinoflagellida | 3 | 2014 | 11 | 0.520 |
Why?
|
| Colobus | 1 | 2016 | 1 | 0.510 |
Why?
|
| RNA Viruses | 1 | 2016 | 22 | 0.500 |
Why?
|
| Culicidae | 1 | 2016 | 26 | 0.500 |
Why?
|
| Viral Envelope Proteins | 3 | 2026 | 91 | 0.460 |
Why?
|
| Humans | 40 | 2026 | 43102 | 0.450 |
Why?
|
| Genomics | 5 | 2019 | 293 | 0.440 |
Why?
|
| Symbiosis | 3 | 2014 | 46 | 0.430 |
Why?
|
| Orthobunyavirus | 1 | 2014 | 5 | 0.420 |
Why?
|
| Selection, Genetic | 2 | 2017 | 75 | 0.420 |
Why?
|
| Acclimatization | 2 | 2013 | 25 | 0.410 |
Why?
|
| Ebola Vaccines | 2 | 2026 | 10 | 0.390 |
Why?
|
| Hot Temperature | 2 | 2014 | 141 | 0.390 |
Why?
|
| Liberia | 9 | 2019 | 13 | 0.380 |
Why?
|
| Simian immunodeficiency virus | 2 | 2024 | 60 | 0.380 |
Why?
|
| Genetic Speciation | 1 | 2012 | 24 | 0.370 |
Why?
|
| Genome, Bacterial | 3 | 2025 | 139 | 0.350 |
Why?
|
| Mutation | 5 | 2024 | 1177 | 0.340 |
Why?
|
| Copepoda | 1 | 2009 | 6 | 0.310 |
Why?
|
| Antibodies, Neutralizing | 3 | 2026 | 127 | 0.300 |
Why?
|
| DNA | 2 | 2022 | 592 | 0.290 |
Why?
|
| Genotype | 4 | 2020 | 800 | 0.290 |
Why?
|
| Metagenomics | 2 | 2021 | 46 | 0.270 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1542 | 0.270 |
Why?
|
| Molecular Epidemiology | 5 | 2020 | 59 | 0.260 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 209 | 0.260 |
Why?
|
| Burkholderia | 2 | 2017 | 17 | 0.250 |
Why?
|
| Glycoproteins | 2 | 2026 | 125 | 0.250 |
Why?
|
| Genetics, Population | 2 | 2022 | 121 | 0.250 |
Why?
|
| California | 2 | 2025 | 548 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 5 | 2019 | 115 | 0.240 |
Why?
|
| Cluster Analysis | 3 | 2016 | 207 | 0.240 |
Why?
|
| Rickettsia Infections | 1 | 2025 | 3 | 0.240 |
Why?
|
| Antibody Formation | 2 | 2022 | 76 | 0.240 |
Why?
|
| Ixodidae | 1 | 2025 | 8 | 0.240 |
Why?
|
| Geography | 4 | 2020 | 110 | 0.230 |
Why?
|
| Virus Replication | 3 | 2024 | 318 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 306 | 0.230 |
Why?
|
| Moraxella | 2 | 2015 | 2 | 0.230 |
Why?
|
| Moraxellaceae Infections | 2 | 2015 | 2 | 0.230 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2025 | 2 | 0.230 |
Why?
|
| Monkey Diseases | 2 | 2015 | 7 | 0.230 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 117 | 0.220 |
Why?
|
| Phlebovirus | 2 | 2015 | 2 | 0.220 |
Why?
|
| Papio | 1 | 2024 | 22 | 0.220 |
Why?
|
| Seroepidemiologic Studies | 1 | 2024 | 74 | 0.220 |
Why?
|
| Serologic Tests | 1 | 2024 | 45 | 0.210 |
Why?
|
| Semen | 4 | 2018 | 57 | 0.210 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2024 | 57 | 0.210 |
Why?
|
| Enterovirus D, Human | 1 | 2023 | 2 | 0.200 |
Why?
|
| Enterovirus Infections | 1 | 2023 | 4 | 0.200 |
Why?
|
| Aedes | 3 | 2019 | 43 | 0.200 |
Why?
|
| Chromosome Mapping | 1 | 2023 | 199 | 0.190 |
Why?
|
| Oligonucleotides | 1 | 2022 | 49 | 0.190 |
Why?
|
| Snakes | 1 | 2022 | 10 | 0.190 |
Why?
|
| Incidence | 3 | 2020 | 1078 | 0.190 |
Why?
|
| Antibodies | 1 | 2022 | 144 | 0.190 |
Why?
|
| Climate Change | 2 | 2013 | 53 | 0.180 |
Why?
|
| Macaca mulatta | 3 | 2021 | 139 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 112 | 0.180 |
Why?
|
| Deoxyribonuclease I | 1 | 2021 | 26 | 0.180 |
Why?
|
| Proviruses | 1 | 2021 | 35 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2024 | 760 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 458 | 0.170 |
Why?
|
| Academies and Institutes | 2 | 2018 | 39 | 0.160 |
Why?
|
| Brucellosis, Bovine | 1 | 2020 | 2 | 0.160 |
Why?
|
| Brucella abortus | 1 | 2020 | 4 | 0.160 |
Why?
|
| Software | 2 | 2020 | 236 | 0.160 |
Why?
|
| Brucellosis | 1 | 2020 | 8 | 0.160 |
Why?
|
| Insect Vectors | 2 | 2017 | 27 | 0.160 |
Why?
|
| Arizona | 1 | 2020 | 139 | 0.160 |
Why?
|
| Lassa Fever | 1 | 2019 | 1 | 0.160 |
Why?
|
| Lassa virus | 1 | 2019 | 1 | 0.160 |
Why?
|
| Antiviral Agents | 2 | 2019 | 195 | 0.150 |
Why?
|
| Sequence Homology | 2 | 2016 | 35 | 0.150 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 40 | 0.150 |
Why?
|
| Peptides | 1 | 2022 | 372 | 0.150 |
Why?
|
| Survivors | 2 | 2018 | 152 | 0.150 |
Why?
|
| DNA, Mitochondrial | 2 | 2012 | 191 | 0.150 |
Why?
|
| Turtles | 1 | 2019 | 31 | 0.150 |
Why?
|
| Macaca fascicularis | 2 | 2015 | 65 | 0.150 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2018 | 14 | 0.150 |
Why?
|
| Viral Proteins | 1 | 2020 | 190 | 0.150 |
Why?
|
| Plasmids | 2 | 2021 | 244 | 0.140 |
Why?
|
| Virulence Factors | 2 | 2017 | 125 | 0.140 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 143 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2024 | 719 | 0.130 |
Why?
|
| Arenaviruses, New World | 1 | 2017 | 1 | 0.130 |
Why?
|
| Arenaviridae Infections | 1 | 2017 | 3 | 0.130 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 11 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2019 | 172 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2017 | 51 | 0.130 |
Why?
|
| Sugar Acids | 1 | 2017 | 1 | 0.130 |
Why?
|
| Chikungunya virus | 1 | 2017 | 18 | 0.130 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 75 | 0.130 |
Why?
|
| Virus Internalization | 1 | 2017 | 36 | 0.130 |
Why?
|
| Female | 10 | 2026 | 24698 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2017 | 91 | 0.130 |
Why?
|
| Nairovirus | 1 | 2016 | 1 | 0.120 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 90 | 0.120 |
Why?
|
| Tularemia | 1 | 2017 | 115 | 0.120 |
Why?
|
| Adult | 6 | 2024 | 13872 | 0.120 |
Why?
|
| Poly U | 1 | 2015 | 2 | 0.120 |
Why?
|
| Francisella tularensis | 1 | 2017 | 116 | 0.120 |
Why?
|
| Primates | 1 | 2016 | 39 | 0.120 |
Why?
|
| Burkholderia mallei | 1 | 2015 | 6 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2015 | 19 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 256 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2015 | 17 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2015 | 74 | 0.120 |
Why?
|
| Bunyaviridae Infections | 1 | 2015 | 7 | 0.120 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2015 | 12 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 96 | 0.110 |
Why?
|
| Macaca | 1 | 2014 | 36 | 0.110 |
Why?
|
| Fever | 1 | 2015 | 62 | 0.110 |
Why?
|
| Middle Aged | 4 | 2024 | 12222 | 0.110 |
Why?
|
| Computational Biology | 2 | 2015 | 327 | 0.100 |
Why?
|
| Phlebotomus Fever | 1 | 2013 | 1 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 1596 | 0.100 |
Why?
|
| Male | 7 | 2024 | 23409 | 0.100 |
Why?
|
| United States | 2 | 2022 | 5205 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1070 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2012 | 123 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 595 | 0.090 |
Why?
|
| Hybridization, Genetic | 1 | 2012 | 25 | 0.090 |
Why?
|
| Serial Passage | 2 | 2024 | 5 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 529 | 0.090 |
Why?
|
| Species Specificity | 3 | 2017 | 286 | 0.090 |
Why?
|
| DNA, Bacterial | 2 | 2025 | 206 | 0.080 |
Why?
|
| RNA | 1 | 2012 | 266 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2026 | 694 | 0.080 |
Why?
|
| Cytochromes b | 1 | 2009 | 8 | 0.080 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 13 | 0.080 |
Why?
|
| Epitopes | 2 | 2022 | 157 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 201 | 0.070 |
Why?
|
| Travel | 2 | 2019 | 36 | 0.070 |
Why?
|
| Mitochondria | 1 | 2012 | 523 | 0.070 |
Why?
|
| Mice | 4 | 2026 | 6644 | 0.070 |
Why?
|
| Brazil | 2 | 2018 | 84 | 0.070 |
Why?
|
| Sierra Leone | 2 | 2019 | 4 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 383 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2020 | 2544 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 2 | 2017 | 37 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 95 | 0.060 |
Why?
|
| Virulence | 2 | 2017 | 246 | 0.060 |
Why?
|
| Vaccines, Synthetic | 1 | 2026 | 80 | 0.060 |
Why?
|
| Recombination, Genetic | 2 | 2017 | 95 | 0.060 |
Why?
|
| Rabbits | 1 | 2025 | 278 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 368 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2024 | 64 | 0.050 |
Why?
|
| Unsafe Sex | 2 | 2015 | 162 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 1410 | 0.050 |
Why?
|
| Base Sequence | 2 | 2015 | 983 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 247 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 279 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2014 | 172 | 0.050 |
Why?
|
| Endonucleases | 1 | 2021 | 18 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 91 | 0.040 |
Why?
|
| Buffaloes | 1 | 2020 | 3 | 0.040 |
Why?
|
| Costa Rica | 1 | 2020 | 9 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2024 | 1621 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2020 | 50 | 0.040 |
Why?
|
| West Indies | 1 | 2019 | 13 | 0.040 |
Why?
|
| Cuba | 1 | 2019 | 33 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 355 | 0.040 |
Why?
|
| Pacific Ocean | 1 | 2019 | 13 | 0.040 |
Why?
|
| Mosquito Control | 1 | 2019 | 15 | 0.040 |
Why?
|
| Adolescent | 2 | 2023 | 6081 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 1 | 2019 | 6 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2018 | 14 | 0.040 |
Why?
|
| Guinea | 1 | 2018 | 3 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 498 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2018 | 66 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2018 | 85 | 0.030 |
Why?
|
| Virus Activation | 1 | 2018 | 38 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2017 | 5 | 0.030 |
Why?
|
| Virus Cultivation | 1 | 2017 | 7 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 29 | 0.030 |
Why?
|
| Culex | 1 | 2017 | 10 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2017 | 16 | 0.030 |
Why?
|
| Climate | 1 | 2017 | 22 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2017 | 143 | 0.030 |
Why?
|
| Rec A Recombinases | 1 | 2017 | 2 | 0.030 |
Why?
|
| Burkholderia Infections | 1 | 2017 | 3 | 0.030 |
Why?
|
| Northern Territory | 1 | 2017 | 4 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 93 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2017 | 79 | 0.030 |
Why?
|
| Internationality | 1 | 2017 | 37 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 112 | 0.030 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2017 | 12 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 135 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 98 | 0.030 |
Why?
|
| Australia | 1 | 2017 | 103 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2016 | 28 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2017 | 91 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.030 |
Why?
|
| Water Microbiology | 1 | 2017 | 81 | 0.030 |
Why?
|
| Nigeria | 1 | 2016 | 92 | 0.030 |
Why?
|
| Arenavirus | 1 | 2015 | 1 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 103 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 96 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 150 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 203 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 317 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 21 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 245 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 134 | 0.030 |
Why?
|
| Coronavirus | 1 | 2015 | 9 | 0.030 |
Why?
|
| Giant Cells | 1 | 2015 | 15 | 0.030 |
Why?
|
| Nose Diseases | 1 | 2015 | 2 | 0.030 |
Why?
|
| Coitus | 1 | 2015 | 12 | 0.030 |
Why?
|
| Flavivirus | 1 | 2015 | 16 | 0.030 |
Why?
|
| Psychodidae | 1 | 2015 | 3 | 0.030 |
Why?
|
| Panama | 1 | 2015 | 6 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 239 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 61 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 478 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1612 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2015 | 67 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2015 | 87 | 0.030 |
Why?
|
| Actins | 1 | 2015 | 164 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 63 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 79 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1175 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 678 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2015 | 171 | 0.030 |
Why?
|
| RNA, Protozoan | 1 | 2014 | 13 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 341 | 0.030 |
Why?
|
| Genes, Protozoan | 1 | 2014 | 18 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 780 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 652 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 236 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 518 | 0.030 |
Why?
|
| Reassortant Viruses | 1 | 2013 | 11 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1546 | 0.030 |
Why?
|
| American Samoa | 1 | 2013 | 18 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2013 | 21 | 0.020 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 22 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1180 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 509 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2018 | 502 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1082 | 0.020 |
Why?
|
| Genome | 1 | 2013 | 149 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 278 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2853 | 0.020 |
Why?
|
| Child | 1 | 2018 | 3443 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 704 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 8214 | 0.010 |
Why?
|